CA Patent

CA2782774A1 — Protein kinase inhibitors

Assigned to Pharmascience Inc · Expires 2014-01-06 · 12y expired

What this patent protects

The present invention relates to a novel family of inhibitors of protein kinases. In particular, the present invention relates to inhibitors of the members of the Tec and Src protein kinase families, more particularly Btk. More particularly, the present invention is directed to …

USPTO Abstract

The present invention relates to a novel family of inhibitors of protein kinases. In particular, the present invention relates to inhibitors of the members of the Tec and Src protein kinase families, more particularly Btk. More particularly, the present invention is directed to a compound of Formula 1: (see Formula 1)

Drugs covered by this patent

Patent Metadata

Patent number
CA2782774A1
Jurisdiction
CA
Classification
—
Expires
2014-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Pharmascience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.